<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Sainsbury&#8217;s partners with Deliveroo to meet demand	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/sainsburys-deliveroo-demand/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/sainsburys-deliveroo-demand/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Tue, 24 Nov 2020 17:37:55 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>
		By: illy coffee partners with Rhône Capital to bolster international expansion - The Investment Observer		</title>
		<link>https://ukinvestormagazine.co.uk/sainsburys-deliveroo-demand/#comment-16437</link>

		<dc:creator><![CDATA[illy coffee partners with Rhône Capital to bolster international expansion - The Investment Observer]]></dc:creator>
		<pubDate>Tue, 24 Nov 2020 17:37:55 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=32204#comment-16437</guid>

					<description><![CDATA[[&#8230;] company continued, saying that the partnership will solidify the global leadership position of illy coffee, and will compliment the transition of [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] company continued, saying that the partnership will solidify the global leadership position of illy coffee, and will compliment the transition of [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Theranexus and BBDF receive ‘favourable’ FDA opinion for drug trial - The Investment Observer		</title>
		<link>https://ukinvestormagazine.co.uk/sainsburys-deliveroo-demand/#comment-16387</link>

		<dc:creator><![CDATA[Theranexus and BBDF receive ‘favourable’ FDA opinion for drug trial - The Investment Observer]]></dc:creator>
		<pubDate>Thu, 19 Nov 2020 14:52:22 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=32204#comment-16387</guid>

					<description><![CDATA[[&#8230;] drug, for juvenile Batten disease. BBDF funded research aimed at validating BBDF-101, which the partnership describes as a “a proprietary combination of drugs based on the synergistic effect of two active [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] drug, for juvenile Batten disease. BBDF funded research aimed at validating BBDF-101, which the partnership describes as a “a proprietary combination of drugs based on the synergistic effect of two active [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Sainsbury&#039;s to cut 3,500 jobs as group swings to loss - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/sainsburys-deliveroo-demand/#comment-16248</link>

		<dc:creator><![CDATA[Sainsbury&#039;s to cut 3,500 jobs as group swings to loss - UK Investor Magazine]]></dc:creator>
		<pubDate>Thu, 05 Nov 2020 08:52:58 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=32204#comment-16248</guid>

					<description><![CDATA[[&#8230;] Sainsbury&#8217;s (LON: SBRY) has announced plans to cut 3,500 jobs. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Sainsbury&#8217;s (LON: SBRY) has announced plans to cut 3,500 jobs. [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
